Source: https://innovationinfo.org/journal/editorial_board_member/Dr-Melpomeni-M-Peppa
Timestamp: 2019-04-22 08:38:33+00:00

Document:
Biography: Dr. Melpomeni M Peppa is working as Associate Professor of Endocrinology in Research Institute and Diabetes Center at Athens University Medical School. She has completed her education and most of her postdoctoral training in Greece. In 1998, she supported her thesis on the relationship of endothelium dysfunction with diabetic angioppathy in Type 1 Diabetes Mellitus. During 1999-2003, she has completed her postdoctoral Research Fellowship in Division of Experimental Diabetes and Aging, Mount Sinai School of Medicine, NY. Since 2003, she is working in the Second Dept of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, Athens University Medical School, Attikon University Hospital, Athens, Greece, as Senior Lecturer in the beginning and now as Assist. Professor in Endocrinology. She has been author in 48 publications, with a mean impact factor: 3.5, H-Index: 18, citations (ISI/Scopus): 998/1298. She has attended many National and International Conferences and Scientific meetings. She has received awards and grants. Reviewer in over 36 articles in peer-review journals and International grants.
M. Peppa-Patrikiou, M. Scordili, A. Antoniou, M. Giannaki, M. Dracopoulou, C. Dacou-Voutetakis. “Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol and other factors”. Diabetes Care 1998; 21 (6): 1004-1007.
M. Peppa-Patrikiou, M. Dracopoulou, C. Dacou-Voutetakis. “Urinary endothelin in adolescents and young adults with insulin dependent diabetes mellitus. Relation to urinary albumin, blood pressure and other factors”. Metabolism 1998; 47(11): 1408-1412.
C. Dacou-Voutetakis, M. Peppa-Patrikiou, M. Dracopoulou. “Urinary free cortisol and its nyctohemeral variation in adolescents and young adults with IDDM: Relation to endothelin 1 and indices of diabetic angiopathy”. Journal of Pediatric Endocrinology and Metabolism, 1998; 11(3): 437-445.
Ι. Vaindirlis, M. Peppa-Patrikiou, M. Dracopoulou, Ι. Μanoli, A. Voutetakis, C. Dacou-Voutetakis. “White coat or stress hypertension in adolescents: Increased values of urinary cortisol and endothelin”. Journal of Pediatrics 2000; 136 (3): 359-64.
M. Liacopoulou, Τ. Alifieraki, A. Katideniou, M. Peppa, M. Maniati, D. Tzikas, E. Hibbs, C. Dacou-Voutetakis. «Maternal expressed emotion and metabolic control of children and adolescents with diabetes mellitus». Psychotherapy and Psychosomatics 2001; 70(2):78-85.
H. Vlassara, W. Cai, J. Crandall, T. Goldberg, R. Oberstein, V. Dardaine, M. Peppa, E. Rayfield. Inflammatory markers are induced by dietary glycotoxins: A pathway for accelerated atherosclerosis in diabetes. Proc Natl Acad Sci 2002; 99(24):15596-601.
WJ. Cai, QD. Cao, L. Zhu, M. Peppa, C. He, H. Vlassara. Oxidative stress-inducing carbonyl compounds from common foods: Novel mediators of cellular dysfunction. Molecular Medicine 2002; 8(7):337-46.
M. Peppa, J. Uribarri, H. Vlassara. Advanced glycoxidation: A new risk factor for cardiovascular disease? (Review). Cardiovascular Toxicology 2002; 2 (4) :275-287.
M. Peppa, T. Goldberg, W. Cai, E. Rayfield, H. Vlassara. Glycotoxins: A missing link in the “Relationship of dietary fat and meat intake and risk of type 2 diabetes in men”. Diabetes Care, 2002; 25 (10): 1898-9.
J. Uribarri, M. Peppa, W. Cai, T. Goldberg, M. Lu, C. He, H. Vlassara. Restriction of dietary glycotoxins markedly reduces AGE toxins in renal failure patients. J Am Soc Nephrol, 2003; 14(3): 728-731.
M. Peppa, C. He, M. Hattori, R. McEvoy, F. Zheng, H. Vlassara. Fetal or Neonatal Low-Glycotoxin Environment Prevents Autoimmune Diabetes in NOD Mice. Diabetes 2003; 52(6):1441-8.
J. Uribarri, M. Peppa, W. Cai, T. Goldberg, S. Baliga, M. Lu, J.A.Vassalotti, H. Vlassara. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kid Dis 2003; 42(3):532-8.
M Peppa, Η. Brem, P. Ehrlich, J. Zhang, W. Cai, Z. Li, A. Croitoru, S. Thung, and H. Vlassara. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes 2003; 52 (11): 2805-2813.
M. Peppa, J. Uribarri, W. Cai, M. Lu, H. Vlassara. Glycoxidation and inflammation in renal failure patients. Am J Kid Dis 2004; 43 (4): 690-696.
T. Goldberg, W. Cai, M. Peppa, V. Dardaine, BS. Baliga, J. Uribarri, H. Vlassara. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 2004; 104(8):1287-91.
W. Cai, JC He, L Zhu, M. Peppa, C Lu, J. Uribarri, H. Vlassara. High Levels of Dietary Advanced Glycation End Products Transform Low-Density Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients. Circulation. 2004;110 (3):285-291.
G. Ioannidis, M. Peppa, P. Rontogianni, M. Callifronas, C. Papadimitriou, G. Chrysanthopoulou, L. Anthopoulos, M. Kesse, N. Thalassinos. Concurrence of microalbuminuria and retinopathy in combination with cardiovascular risk factors: reliable detection of asymptomatic coronary artery disease in type 2 diabetes. Hormones 2004; 3 (3):198-204.
Μ. Peppa, J..Uribarri, H. Vlassara. The role of advanced glycation end products in the development of atherosclerosis. (Review). Curr Diab Rep. 2004;4(1):31-6.
J. Uribarri, W. Cai, O. Sandu, M. Peppa, T. Goldberg, H. Vlassara. Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Ann N.Y. Acad. Sci 2005; 1043: 461-466.
M. Peppa, H. Vlassara. Advanced glycation end products and diabetic complications. A General overview. Hormones 2005; 4 (1):28-37.
M. Peppa, H. Brem, W.Cai, J. Basgen, L. Zhu, M. Lu, C. Lu, J. Uribarri, H. Vlassara. Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). Am J Nephrol 2006; 26:430-455.
WJ. Cai, L. Zhu, H. Chen, J. Uribarri, M. Peppa. Association of advanced glycoxidation end products and inflammation markers with thrombosis of arteriovenous grafts in hemodialysis patients. Am J Nephrol 2006;26: 181-185.
J. Uribarri, WJ Cai, M. Peppa, S. Goodman, L Ferrrucci, G. Striker, H. Vlassara. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007,62(4):427-33.
G. Dimitriadis, I. Maratou, E. Boutati, A. Kollias, C. Tsegka, M. Alevizaki, M. Peppa, SA Raptis, D. Hatjidakis. Insulin-like growth factor 1 increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism. European Journal of Endocrinology 2008; 158(3), 361-66.
M. Peppa, SA Raptis. Advanced glycation end products and cardiovascular Disease. Current Diabetes Reviews 2008; 4 (2):92-100.
M. Peppa, H. Boutati, S. Kamakari, V. Pikounis, G. Peros, G. Koutsodontis, V. Metaxa- Mariatou, T. Economopoulos, S. A. Raptis, D. Hadjidakis. Novel Germline Mutations of the MEN1 Gene in Greek Families with Multiple Endocrine Neoplasia Type 1. Clin Endocrinol (Oxf). 2009 ;70(1):75-81.
K. Saltiki, A. Cimponeriu, K. Lili, M. Peppa, E. Anastasiou, M. Alevizaki. Severity of coronary artery disease in postmenopausal diabetic women. Hormones 2008; 7 (2): 148-156.
Μ. Peppa, E. Boutati, S. Kamakari, V. Pikounis, G. Peros, I. Panayiotides, T. Economopoulos, SA Raptis, D. Hadjidakis. Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene. Eur J Endocrinol. 2008 ;159(6):767-71.
M. Peppa, J. Uribarri, H. Vlassara. “Aging and glycoxidant stress” Hormones 2008; 7 (2): 123-133.
E.Maratou, D. Hadjidakis, A. Kollias, K. Tsegka, M. Peppa, M. Alevizaki, P. Mitrou, V. Lambadiari, Boutati E, D. Nikzas, N. Tountas, T. Economopoulos, SA Raptis, G. Dimitriadis. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol.2009; 160 (5):785-90.
M. Peppa, P. Stavroulakis, S.A. Raptis. Advanced Glycoxidation Products and Impaired Diabetic Wound Healing (Review). Wound Rep Reg 2009; 17(4): 461–472.
M. Peppa, Ε. Brountzos, N. Economopoulos, E. Boutati, V. Pikounis, P. Patapis, T. Economopoulos, S. A. Raptis, D. Hadjidakis. Embolization as an alternative treatment of insulinoma in a patient with multiple endocrine neoplasia syndrome type 1. Cardiovasc Intervent Radiol. 2009 ;32(4):807-11.
M. Peppa, I. Ekonomidis, D. Hadjidakis, V. Pikounis, J Paraskevaidis, T. Economopoulos, SA Raptis, ST Kremastinos. Dilated cardiomyopathy as the predominant feature of Cushing’s syndrome. American Journal of Medical Sciences 2009; 338(3):252-3.
M. Peppa, G. Papaxoinis, D. Hadjidakis, N. Xiros, SA Raptis, T. Economopoulos, D. Hadjidakis. Case report: Panhypopituitarism due to metastases to the hypothalamus and the pituitary resulting from primary breast cancer.A case report and review of the literature. Clinical Breast Cancer 2009 ; 9 (4) : E4-7.
M. Peppa, V. Pikounis, G. Papaxoinis, A. Macheras, T. Economopoulos, S. A. Raptis, D. Hadjidakis. Adrenocortical carcinoma secreting cortisol, androgens and aldosterone: a case report. Cases Journal 2009;10(2): 8951.
M. Peppa, E. Boutati, C. Koliaki, P. Nikolopoulos, N. Papaefstathiou, T. Economopoulos, D. Hadjidakis, S.A. Raptis. Insulin resistance and metabolic syndrome in patients with non-functioning adrenal incidentalomas: A cause-effect relationship? Metabolism 2010; 59(10):1435-41.
E. Maratou, DJ. Hadjidakis, M. Peppa, M. Alevizaki, K Tsegka, V. Lambadiari, P. Mitrou, E. Boutati, A. Kollias, T. Economopoulos, SA Raptis, G. Dimitriadis. Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. Eur J Endocrinol. 2010; 163(4):625-30.
M. Peppa, C. Koliaki, P. Nikolopoulos, S.A. Raptus. Skeletal muscle insulin resistance in endocrine disease. Journal of Biomedicine and Biotechnology, 2010.
M. Peppa, C. Koliaki, S.A. Raptis. Adrenal Incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications Journal of Intern Med 2010; 268 (6): 555-66.
M. Peppa, D. Vlahakos. Are we satisfied with the follow-up of hypertensive and chronic kidney disease patients in outpatient clinics? Hippokratia 2010.
M. Peppa, E. Karamitopoulou, P. Nikolopoulos, G. Peros, T. Economopoulos, S. A. Raptis, D. Hadjidakis. Large adrenal oncocytoma with uncertain malignant potential. a case report and review of the literature. Endocr Pract. 2010; 16(4):641-5.
M. Peppa, M. Dracopoulou-Vabouli, S. A. Raptis. Bilateral adrenal myelolipomas associated with 21-hydroxylase deficiency. Endoc Prac 2010; 16(3):525-6.
P. Ferentinos, E. Rizos, A. Douzenis, A. Papadopoulou, C. Christodoulou, M. Peppa, L. Lykouras. Androgen insensitivity and liability to drug-induced extrapyramidal symptoms. Gender Medicine, 2011; 8(2): 156-60.
M. Peppa, R. Betsi, G. Dimitriadis. Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease. J Lipids. 2011;2011: 575840.
M. Peppa, S.A. Raptis. Glycoxidation and Wound Healing in Diabetes: An Interesting Relationship Current Diabetes Reviews, 2011; 7: 416-425.
M. Peppa, Μ. Κrania, S.A. Raptis. Hypertension and other morbidities with Cushing’s syndrome associated with corticosteroids. A review. Journal of Integrated Blood Pressure Control 2011; 4:7-16.
M. Peppa, P.Nikolopoulos, P. Korkolopoulou, D. Lapatsanis, G. Dimitriadis, D. Hadjidakis, S.A Raptis. Primary MALT thyroid lymphoma: A rare thyroid neoplasm of extrathyroid origin. Journal of Rare Tumors 2011, 2012.
E. Tsigkaropoulou, M. Peppa, C. Zompola, E. Rizos, I. Xelioti, S. Chatziioannou, A.Filippopoulou, "Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis” Gender Medicine 2012;9(1):56-60.
Ε. Trakakis, G. Basios, M. Peppa, G. Simeonidis, G. Labos, M. Creatsa, M. Misailidou, E. Boutati, V. Vaggopoulos, P. Panagopoulos, G. Dimitriades, D. Kassanos. The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome. Gynecol Endocrinol 2012; 28(11): 867-70.
M. Peppa, C. Koliaki, A. Papaefstathiou, E. Garoflos, N. Katsilambros, S. A. Raptis, D. Hadjidakis, G. D. Dimitriadis. Body Composition Determinants of Metabolic Phenotypes of Obesity in Nonobese and Obese Postmenopausal Women. Obesity (Silver Spring) 2013; 21(9): 1807-14.
M. Peppa, C. Koliaki*, E. Boutati, E. Garoflos, A. Papaefstathiou, N. Siafakas, N. Katsilambros, S. A. Raptis, D. Hadjidakis, G.D. Dimitriadis. Association of Lean Body Mass with Cardiometabolic Risk Factors in Healthy Postmenopausal Women. Obesity (Silver Spring) 2014; 22(3):828-35.
M. Peppa, C. Koliaki D. Hadjidakis, E. Garoflos, A. Papaefstathiou, N. Katsilambros, SA Raptis, GD Dimitriadis. Regional fat distribution and cardiometabolic risk in healthy postmenopausal women. Eur J Intern Med 2013; 24(8): 824-31.
Ν. Papadopoulou, C. Skevaki, M. Peppa, I. Kosteria, I. Papasotiriou, G. Chrousos, C. Kanaka-Gantenbein. NGAL, GDF-15 and YKL-40: Early markers of diabetic nephropathy in young patients with Type 1 diabetes mellitus: One year follow up. Hormones.
Hatzioannou, I. Kanistras, E. Mantzou, E. Anastasiou, M. Peppa, V. Sarantopoulou, P. Lymberi, M. Alevizaki. Effect of Advanced Glycation End Products on Human Thyroglobulin's Antigenicity as Identified by the Use of Sera from Patients with Hashimoto's Thyroiditis and Gestational Diabetes Mellitus. Int J Endocrinol. 2015;2015: 849615.
E. Rizos, K. Tournikioti, E. Alevyzakis, M. Peppa, K. Papazaxos, G. Zorbas, I. Michopoulos, I. Liappas, C. Papageorgiou, A. Douzenis. Acute Necrotizing Pancreatitis Following Olanzapine Treatment and 759C/T Polymorphism of HTR2C Gene: A Case Report. In Vivo. 2015 Sep-Oct;29(5):529-31.
D. Xirofotos, E. Trakakis, M. Peppa, C. Chrelias, P. Panagopoulos, C. Christodoulaki, D. Sioutis, D. Kassanos. The amount and duration of smoking is associated with aggravation of hormone and biochemical profile in women with PCOS. Gynecol Endocrinol. 2016 ;32(2):143-6.
D. Kaldrymidis, G. Papadakis, G. Tsakonas, I. Kostoglou-Athanassiou, P. Kaldrymidis, P. Roussou, E. Diamanti-Kandarakis, M. Peppa. Quality of Life in Acromegaly and the Association with the Clinical Parameters of the Disease. Endocrinology and Metabolism Journal 2017: 4: 1-4.
C. Stefanaki, M. Peppa, D. Boschiero, G.P. Chrousos. Healthy overweight/obese youth: Early Osteosarcopenic Obesity Features. Eur J Clin Invest. 2016 Sep;46(9):767-78.
D. Kaldrymidis, G. Papadakis, G. Tsakonas, P. Kaldrymidis, T. Flaskas, A. Seretis, E. Pantazi, I. Kostoglou-Athanassiou, M. Peppa, P. Roussou, E. Diamanti-Kandarakis. High Incidence of Thyroid Cancer among Patients with Acromegaly. J BUON 2016; 21(4):989-993.
V. Christodoulopoulou, E. Trakakis, V. Pergialiotis, M. Peppa, C. Chrelias, D. Kassanos, N. Papantoniou. Clinical and biochemical characteristics associated with menstrual abnormalities in women with PCOS. J Family and Reproductive Health 2017.
C. Stefanaki, M. Peppa, G. Mastorakos, Gp. Chrousos. Examining the gut bacteriome, virome, and mycobiome in glucose metabolism disorders: Are we on the right track? Metabolism. 2017 Aug;73: 52-66.
M. Peppa, C. Stefanaki, A. Papaefstathiou, D. Boschiero, G. Dimitriadis, GP Chrousos. Bioimpedance analysis vs. DEXA as a screening tool for osteosarcopenia in lean, overweight and obese Caucasian postmenopausal females. Hormones (Athens). 2017 Apr;16(2):181-193.
C. Stefanaki, F. Bacopoulou, M. Peppa. Prediabetes in adolescence – Trends, causes, effects, and screening. US Endocrinology 2016; 12(2): 1-6.
E. Diamanti-Kandarakis, M. Dattilo, D. Macut, L. Duntas, ES Gonos, DG Goulis, CK Gantenbein, M. Kapetanou, E.Koukkou, I. Lambrinoudaki, M. Michalaki, S Eftekhari-Nader, R. Pasquali, M. Peppa, M Tzanela, E, Vassilatou, A. Vryonidou A; COMBO ENDO TEAM: 2016. MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview. Eur J Endocrinol. 2017 Jun;176(6): R283-R308.
k. Tsevis, E. Trakakis, V. Pergialiotis, E. Alhazidou, M. Peppa, C Chrelias, N. Papantoniou, P Panagopoulos. The influence of thyroid disorders on bone density and biochemical markers of bone metabolism. Horm Mol Biol Clin Investig. 2018 15;35(1).
Papadopoulos, W. Bountouvi, A. Attilakos, E. Gole, A. Dinopoulos, M. Peppa, P. Nikolaidou, A. Papadopoulou, A. Attilakos A. Clinical and genetic characterization of 10 new osteoporosis-pseudoglioma (OPPG) cases and response to treatment (European Journal of Pediatrics 2018.
M. Peppa, J. Uribarri, H. Vlassara. Glucose, advanced glycation end products (AGE) and diabetic complications. Clin Diabetes 2003, 21(4):186-188, αναφορ?ς n=28.
M. Peppa, C. Koliaki, G. Dimitriadis. Body Composition as an Important determinant of Metabolic Syndrome in Postmenopausal Women. Endocrine & Metabolic Syndrome”.
L. Kolilekas, E.Manali, M. Peppa, T. Chamogeorgakis, A. Papadopoulou, C. triantafyllidou, K. Kagouridis, D. Rontogianni, A. Karakatsani, S. Papiris. Usual interstitial pneumonia in a patient with celiac disease and polyglandular syndrome IIIA. Pneumon 2014; 2794):345-34932.
G. Koukoulis, A. Melidonis, K. Milios, Mellita Investigators. Quality of Life of Insulin-Naïve People with Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Drugs after the Addition of Insulin Glargine, in Every Day Clinical Practice in Greece. J Diabetes Metab Disord Control 2015; 2(2): 00037.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 

V. 
 V. 
 V.